Application 208494
- Type
- ANDA
- Sponsor
- REYOUNG PHARMA CO LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | SILDENAFIL CITRATE | SILDENAFIL CITRATE | TABLET;ORAL | 25MG | No | No |
| 002 | SILDENAFIL CITRATE | SILDENAFIL CITRATE | TABLET;ORAL | 50MG | No | No |
| 003 | SILDENAFIL CITRATE | SILDENAFIL CITRATE | TABLET;ORAL | 100MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 35561-251 | Sildenafil | sildenafil | AustarPharma LLC | ANDA | Current |
| 35561-252 | Sildenafil | sildenafil | AustarPharma LLC | ANDA | Current |
| 35561-253 | Sildenafil | sildenafil | AustarPharma LLC | ANDA | Current |
| 82647-210 | Sildenafil | sildenafil | Reyoung Corporation | ANDA | Current |
| 82647-211 | Sildenafil | sildenafil | Reyoung Corporation | ANDA | Current |
| 82647-212 | Sildenafil | sildenafil | Reyoung Corporation | ANDA | Current |